Abstract
How might increased funding and new initiatives help tackle the challenges of collecting and monitoring data on the safety of prescription drugs?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Jones, D. Keeping vigilant about drug safety. Nat Rev Drug Discov 6, 855–856 (2007). https://doi.org/10.1038/nrd2455
Issue Date:
DOI: https://doi.org/10.1038/nrd2455
This article is cited by
-
Beyond debacle and debate: developing solutions in drug safety
Nature Reviews Drug Discovery (2009)
-
2007: Spotlight on drug safety
Nature Reviews Drug Discovery (2008)